Combined modality therapy of esophageal cancer

Rosalyn A. Juergens, Arlene Forastiere

Research output: Contribution to journalReview article

Abstract

Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multi-modality approaches to the management of esophageal cancer.

Original languageEnglish (US)
Pages (from-to)851-860
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume6
Issue number9
DOIs
StatePublished - Oct 2008

Keywords

  • Chemoradiotherapy
  • Chemotherapy
  • Esophageal cancer
  • Neoadjuvant

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Combined modality therapy of esophageal cancer'. Together they form a unique fingerprint.

  • Cite this